Was ist die Webseite?

Antibodies MDPI

Startseite
Schweiz
Basel
Antibodies MDPI

Antibodies MDPI Antibodies (ISSN 2073-446, IF 3.0), is an Open Access journal of Antibodies and Antigens published online by
MDPI.

15/01/2025

Welcome to read the highly cited paper
Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes
by Daniel Chiu et al.
👉The link: https://bit.ly/40aB0f3

10/01/2025

Welcome to read the highly cited paper
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
by Toshihiko Tashima
👉The link: https://www.mdpi.com/2073-4468/12/3/43

08/01/2025

Welcome to read the highly cited paper
Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
by Weronika Grąźlewska and Lucyna Holec-Gąsio
👉The link: https://www.mdpi.com/2073-4468/12/4/63

06/01/2025

Welcome to read the highly cited paper
Effects of Monovalent Salt on Protein-Protein Interactions of Dilute and Concentrated Monoclonal Antibody Formulations
by Amy Y. Xu et al.
👉The link: https://bit.ly/40bgPfI

02/01/2025

Welcome to read the highly cited paper
Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo
by Jessica Bourque and Daniel Hawiger
👉The link: https://bit.ly/4gxegeG

30/12/2024

Welcome to read the highly cited paper
Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance
by Priscilla Gomes da Silva
👉The link: https://bit.ly/3BBcREU

23/12/2024

📚Welcome to read the highly cited paper
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by Hernando Vargas-Uricoechea
👉The link: https://bit.ly/4fw0W92

20/12/2024

Welcome to read the highly cited paper
Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect
by Toshihiko Tashima
👉The link: https://bit.ly/3P3bO3v

18/12/2024

Welcome to read the highly cited paper
Precision-Cut Tumor Slices (PCTS) as an Ex Vivo Model in Immunotherapy Research
by Paraskevi Dimou et al.
👉The link: https://bit.ly/3Daydcr

09/12/2024

Welcome to read the highly cited paper
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
by Thomas Böldicke
👉The link: https://bit.ly/4fadIdp

05/12/2024

Welcome to read the highly cited paper
Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C—Can We Match the Puzzle?
by Snezhina Lazova et al.
👉The link: https://bit.ly/3D9EKE8

03/12/2024

Welcome to read the highly cited paper
Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics
by Taihei Murakami et al.
👉The link: https://bit.ly/3ZjlpYF

28/11/2024

Welcome to read the highly viewed paper
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
by Tsvetelina Velikova et al.
👉The link: https://bit.ly/3ZgS6Gm

27/11/2024

Welcome to read the highly viewed paper
Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS
by Emmanuel J. Favaloro et al.
👉The link: https://bit.ly/3Z9cA3L

25/11/2024

Welcome to read the highly cited paper
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by Aubin Pitiot et al.
👉The link: https://bit.ly/4fHzLZI

22/11/2024

Welcome to read the highly cited paper
Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
by Brian A. Baldo
👉The link: https://bit.ly/4fZDqlG

21/11/2024

To promote the academic exchange of young scientists and support the Editorial Board with additional expertise, the Early Career Editorial Board of Antibodies is being set up.
⏰Application deadline: 1 January 2025.
The link: https://bit.ly/3CPlAmM

06/11/2024

Welcome to read the highly viewed paper
TLR7 and IgM: Dangerous Partners in Autoimmunity
by Timm Amendt and Philipp Yu
The link: https://bit.ly/3YPl9BJ

Adresse

Basel

Webseite

https://www.mdpi.com/journal/antibodies

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Antibodies MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.